Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To evaluate the tolerability and safety of a single oral dose of ZL-65 tablets in healthy adult trial participants through dose escalation; and to preliminarily assess the pharmacokinetic and pharmacodynamic characteristics of a single oral dose of ZL-65 tablets.Exploring the impact of food intake on the PK of orally administered ZL-65 tablets in healthy adult trial participants.
Epistemonikos ID: b71af5b5d50338ab2d6920446e102a5d64a2de35
First added on: Aug 12, 2026